Creative Medical Technology Holdings, Inc.

Name: Creative Medical Technology Holdings, Inc. standardized financial statements, quarterly
Creator: Listed

CELZNasdaqCIK 1187953HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026

Operating income−$1.6m, Q2 FY2026

Net income−$1.5m, Q2 FY2026

Creative Medical Technology Holdings, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	6.0	3.0	0.0	8.0	0.0	3.0	3.0	0.0	0.0	3.0	0.0	0.0
Cost of revenue	$k	2.4	1.2	0.0	3.2	0.0	1.2	1.2	0.0	0.0	1.0	0.0	0.0
Gross profit	$k	3.6	1.8	0.0	4.8	0.0	1.8	1.8	0.0	0.0	2.0	0.0	0.0
Research and development	$k	993	349	422	925	582	472	743	501	465	550	542	459
Selling, general and administrative	$k	531	1,399	671	676	499	1,393	888	732	777	1,367	889	1,080
Operating income	$k	(1,543)	(1,772)	(1,123)	(1,625)	(1,110)	(1,886)	(1,660)	(1,264)	(1,273)	(1,946)	(1,459)	(1,562)
Interest expense	$k	not reported	not reported	0.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Income tax	$k	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net income	$k	(1,454)	(1,679)	(1,042)	(1,558)	(1,040)	(1,854)	(1,638)	(1,233)	(1,236)	(1,888)	(1,405)	(1,512)
Diluted EPS	$ per share	not reported	not reported	0.73	(1.11)	(0.75)	not reported	(0.83)	(0.48)	(0.48)	not reported	(0.38)	(0.41)
Basic EPS	$ per share	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported

Balance sheet

Cash and equivalents$3.5m, FY2023

Shareholders' equity$8.7m, Q2 FY2026

Creative Medical Technology Holdings, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	4.5	3.5	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current assets	$m	12.0	10.3	9.2	7.6	6.3	6.1	7.8	6.6	5.4	7.4	6.1	9.0
Total assets	$m	12.5	10.7	9.6	8.0	6.9	6.7	8.3	7.1	5.9	7.8	6.4	9.4
Current liabilities	$m	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.7
Total liabilities	$m	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.7
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	12.1	10.3	9.2	7.6	6.6	6.3	8.1	6.8	5.6	7.5	6.1	8.7

Cash flow

Operating cash flow−$1.5m, Q2 FY2026

Share repurchases$0, Q2 FY2026

Creative Medical Technology Holdings, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(1,305)	(1,895)	(897)	(1,469)	(986)	(1,950)	(1,592)	(1,159)	(1,169)	(1,938)	(1,323)	(1,472)
Share repurchases	$k	192	79.2	82.8	66.7	25.5	0.0	10.0	0.0	0.0	0.0	0.0	0.0

Diluted shares (weighted)3.70m, Q2 FY2026

Creative Medical Technology Holdings, Inc., shares, quarterly
Line item	Unit	Q3 FY20202020-09-30	Q1 FY20212021-03-31	Q3 FY20212021-09-30	Q3 FY20222022-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	2.5	1,245	2.5	14.1	1.4	1.4	1.4	2.0	2.6	2.6	3.7	3.7

Shares outstanding: 6.59m at Aug 7, 2026, from the cover of the 10-Q filed Aug 7, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. Listed shows no prices and gives no investment advice.